iRhythm Technologies Inc (IRTC)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.05B
Last updated: Nov 17, 2026 at 11:06 AM ET
iRhythm Technologies Inc (IRTC) Stock Forecast
Analysts expect iRhythm Technologies (IRTC) to earn $1.27 per share in the fiscal year ending Dec 31, 2026, on revenue of $893.10M. Of 16 analysts, 16 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 16 ratings average 1.81, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 18.8% |
| Buy | 13 | 81.3% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 16
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 22.8% and revenue estimates rise 19.8%.
- Fiscal year ending Dec 31, 2026
- $1.27
- EPS consensus, revenue $893.10M
- Fiscal year ending Dec 31, 2027
- $1.56
- EPS consensus, revenue $1.07B
- Next report
- Feb 17, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.27 | $1.15 to $1.43 | 10 | $893.10M | $891.20M to $895.76M | 16 |
| Dec 31, 2027 | $1.56 | $0.85 to $2.08 | 11 | $1.07B | $1.06B to $1.08B | 16 |
Quarterly Estimates
The EPS consensus falls from $0.16 for the quarter ending Dec 31, 2026 to -$0.12 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.16 | $0.05 to $0.31 | 18 | $252.87M | $241.08M to $263.13M | 18 |
| Mar 31, 2027 | -$0.12 | -$0.35 to $0.23 | 10 | $243.49M | $237.60M to $256.67M | 12 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 3 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 119.0% from $0.58.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $1.27 | $0.45 | $0.47 | $0.58 | $0.58 | +116.5% |
| Fiscal year ending Dec 31, 2027 | $1.56 | $1.20 | $1.19 | $1.19 | $1.18 | +32.6% |
| Quarter ending Mar 31, 2027 | -$0.12 | -$0.20 | -$0.20 | -$0.19 | -$0.15 | N/A |
Frequently Asked Questions About IRTC
What is the IRTC stock forecast?
Consensus analyst estimates put iRhythm Technologies's EPS at $1.27 for the fiscal year ending Dec 31, 2026, on revenue of $893.10M. The consensus rating from 16 analysts is Buy.
How do analysts rate IRTC stock?
Of 16 analysts covering iRhythm Technologies, 3 rate it Strong Buy, 13 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from IRTC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.27, with estimates from $1.15 to $1.43 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.56, with estimates from $0.85 to $2.08 from 11 analysts.
What revenue do analysts expect from iRhythm Technologies next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $893.10M, with estimates from $891.20M to $895.76M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.07B, with estimates from $1.06B to $1.08B.
How many analysts cover IRTC?
16 analysts rate iRhythm Technologies stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
IRTC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors